Back to results
US 10,328,128 B2Granted
Treatment of infection by human enterovirus D68
AssigneeAnsun Biopharma, Inc.
InventorRonald B. Moss
Life of this patent
Estimating the term…
Abstract
The present disclosure provides compositions and methods for treating an infection by EV-D68. In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by EV-D68.
Claims6
A method of treating infection by EV-D68 in a patient, the method comprising administering by inhalation to the patient an effective amount of DAS181.
Dependencies are inferred from the claim text.